EAM Investors’s Apollo Endosurgery, Inc. APEN Stock Holding History

EAM Investors’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-139,564	Closed	-$1.18M	–	422
2021 Q4	$1.18M	Sell	139,564 -70,142	-33%	-$613K	0.19%	250
2021 Q3	$1.9M	Hold	209,706	–	–	0.32%	133
2021 Q2	$1.7M	Buy	+209,706	New	+$1.44M	0.26%	173
2018 Q4	–	Sell	-87,279	Closed	-$626K	–	343
2018 Q3	$626K	Buy	+87,279	New	+$678K	0.09%	285

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

EAM Investors's APEN Position: Q1 2022 in Review

EAM Investors sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2022, closing a stake of 139,564 shares — an estimated $1.18M sold.

EAM Investors first reported a position in APEN in Q3 2018 and held it in 4 quarters. The position peaked at $1.9M in Q3 2021. 71 funds tracked by Wall St. Rank hold APEN as of Q1 2022.

EAM Investors reported no remaining Apollo Endosurgery, Inc. position as of Q1 2022 after selling out during the quarter.
EAM Investors sold 139,564 Apollo Endosurgery, Inc. shares in Q1 2022, an estimated $1.18M.
EAM Investors first reported a position in Apollo Endosurgery, Inc. in Q3 2018 and held it in 4 quarters.
EAM Investors's Apollo Endosurgery, Inc. position peaked at $1.9M in Q3 2021.
71 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2022.

Based on EAM Investors's 13F filing for Q1 2022, filed 13 May 2022.